XML 17 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Revenues $ 499 $ 150 $ 920 $ 533
Cost of revenues 271 51 407 345
Gross profit 228 99 513 188
Operating expenses:        
Research and development 50 68 178 131
Selling and marketing 245 289 852 723
General and administrative 801 546 2,656 2,513
Total operating expenses 1,096 903 3,686 3,367
Loss from operations (868) (804) (3,173) (3,179)
 Interest expense (123) (123)
Financial income (expense), net (23) (15) (29) (25)
Change in fair value of derivative liabilities (5,714) (6,956)
Gain on purchase of warrants 64
Warrant modification expense (1,627)
Loss before taxes on income (6,605) (942) (11,721) (3,327)
Income tax benefit / (expense) (70) 20 (87) 7
Net loss $ (6,675) $ (922) $ (11,808) $ (3,320)
Basic and diluted net loss available for holders of common stock, Series C Preferred Stock and Series D Preferred Stock $ (0.26) $ (0.10) $ (0.47) $ (0.43)
Weighted average common shares outstanding:        
Basic and diluted 26,096,957 9,344,254 25,014,919 7,649,242
Comprehensive loss:        
Net loss available to common stockholders $ (6,675) $ (922) $ (11,808) $ (3,320)
Change in foreign currency translation adjustments 1 (7)
Comprehensive loss available to common stockholders $ (6,674) $ (922) $ (11,815) $ (3,320)